Topsalysin: Additional Phase IIa data

Data from an open-label, U.K. Phase IIa trial in 18 patients with localized prostate cancer showed that

Read the full 179 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE